Actualités CalciMedica Inc - CALC | Actions NASDAQ

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates PR...

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH...

CalciMedica Announces Upcoming Presentations and Events in September

CalciMedica Announces Upcoming Presentations and Events in September PR Newswire LA JOLLA, Calif., Sept. 6...

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 PR Newswire LA JOLLA...

CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

International expansion of CARPO, a Phase 2b clinical trial of Auxora in acute pancreatitis (AP) patients with...

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CARPO top-line data expected in 1H2024 CARPO enrolling in over 30 sites in the US and India LA JOLLA, Calif...

CalciMedica Announces Relisting on Nasdaq

LA JOLLA, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a...

CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)

Results support the initiation of clinical studies to assess Orai1 inhibition in patients with recurrent acute...

California Coastal Communities to Begin Solicitation of Creditors to Confirm Plan of Reorganization and Emerge From Bankruptcy

California Coastal Communities to Begin Solicitation of Creditors to Confirm Plan of Reorganization and Emerge From Bankruptcy - Court Hearing to...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CalciMedica Inc (CALC)

Outils de qualité professionnelle, pour des investisseurs individuels.

CALC Actualités

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

CalciMedica Announces Upcoming Presentations and Events in September

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Relisting on Nasdaq

CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)

CalciMedica Expands Executive Team with New Appointments

CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Current Report Filing (8-k)

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

California Coastal Communities Obtains Court Confirmation of Plan of Reorganization

California Coastal Communities to Begin Solicitation of Creditors to Confirm Plan of Reorganization and Emerge From Bankruptcy

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CalciMedica Inc (CALC) Actualités

CalciMedica Inc (CALC)

Outils de qualité professionnelle, pour des investisseurs individuels.

CALC Actualités

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

CalciMedica Announces Upcoming Presentations and Events in September

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Relisting on Nasdaq

CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)

CalciMedica Expands Executive Team with New Appointments

CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Current Report Filing (8-k)

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

California Coastal Communities Obtains Court Confirmation of Plan of Reorganization

California Coastal Communities to Begin Solicitation of Creditors to Confirm Plan of Reorganization and Emerge From Bankruptcy

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités